Rare disease is a word used to describe pathological disorders that have a very low incidence and prevalence. According to the "Rare Condition Act," passed in the United States in 2002, a disease must affect fewer than 200,000 Americans and have a prevalence equal to or less than 1 in 1,500 people to be classified as rare. The skeletal system, on the other hand, may be impacted by rare disorders of unknown aetiology for which no genetic aetiology has been identified, only a genetic predisposition. The musculoskeletal system is affected by orthopaedic injuries and disorders. Muscles, bones, nerves, joints, ligaments, tendons, and other connective tissues are all part of this bodily system. Chronic orthopaedic conditions or an injury might cause damage to any of these tissues or structures. Variations in genes that control skeletal development and regulation are responsible for several uncommon disorders affecting the musculoskeletal system. Understanding the genetic foundation and phenotypic connections, depending on the type and position within the same gene, has been made possible by recent developments in molecular genetics. Almost 400 different types of skeletal dysplasias have been identified so far.
Title : Management and outcomes of metastatic disease to Intra-articular synovium, literature review
Al Yaqadhan Al Kindi, Sultan Qaboos University, Oman
Title : Smartphone injuries and importance of regular exercise to prevent injuries
Maya John, Al Ain Hospital, United Arab Emirates
Title : The associated life style factors on knee pain among the patients attending the Orthopedic Clinic in Teaching Hospital Jaffna
I M T M Illangasinghe, University of Jaffna, Sri Lanka
Title : Platelet-Rich Plasma (prp) as a therapeutic approach for joint osteoarthritis: A focus on regenerative potential and quality control in clinical trials
Hany Abu Farsakh, Private Clinic, Jordan
Title : Revolutionizing orthopedics: The future of biomechanics through Artificial Intelligence
Moataz Eltoukhy, University of Miami, United States
Title : Adenosine, Lidocaine and Magnesium (ALM) therapy modulates early sex-specific inflammatory, immune responses and augments joint tissue healing following experimental anterior cruciate ligament rupture and reconstruction
Jodie Morris, James Cook University , Australia